Biomolecular condensates in cell biology and virology: Phase-separated membraneless organelles (MLOs).
Membraneless organelles (MLOs) in the cytoplasm and nucleus in the form of 2D and 3D phase-separated biomolecular condensates are increasingly viewed as critical in regulating diverse cellular functions. These functions include cell signaling, immune synapse function, nuclear transcription, RNA splicing and processing, mRNA storage and translation, virus replication and maturation, antiviral mechanisms, DNA sensing, synaptic transmission, protein turnover and mitosis. Components comprising MLOs often associate with low affinity; thus cell integrity can be critical to the maintenance of the full complement of respective MLO components. Phase-separated condensates are typically metastable (shape-changing) and can undergo dramatic, rapid and reversible assembly and disassembly in response to cell signaling events, cell stress, during mitosis, and after changes in cytoplasmic "crowding" (as observed with condensates of the human myxovirus resistance protein MxA). Increasing evidence suggests that neuron-specific aberrations in phase-separation properties of RNA-binding proteins (e.g. FUS and TDP-43) and others (such as the microtubule-binding protein tau) contribute to the development of degenerative neurological diseases (e.g. amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer's disease). Thus, studies of liquid-like phase separation (LLPS) and the formation, structure and function of MLOs are of considerable importance in understanding basic cell biology and the pathogenesis of human diseases.
['Sehgal|Pravin B|PB|', 'Westley|Jenna|J|', 'Lerea|Kenneth M|KM|', 'DiSenso-Browne|Susan|S|', 'Etlinger|Joseph D|JD|']
D003585:Cell Biology D002467:Cell Nucleus D003593:Cytoplasm D006801:Humans D064547:Myxovirus Resistance Proteins D015388:Organelles
Biomolecular condensates Membraneless organelles (MLOs) Liquid-like phase separation (LLPS) 2D and 3D supramolecular assemblies Cytoplasmic crowding Myxovirus-resistance proteins MxA and Mx1 Neurodegenerative diseases